Compare IQV & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | DOV |
|---|---|---|
| Founded | 1982 | 1947 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 28.8B |
| IPO Year | 2013 | 1994 |
| Metric | IQV | DOV |
|---|---|---|
| Price | $262.33 | $202.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | $227.13 | ★ $240.17 |
| AVG Volume (30 Days) | ★ 1.2M | 902.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | 1.61 | ★ 4.06 |
| Revenue | ★ $9,739,000,000.00 | $6,992,118,000.00 |
| Revenue This Year | $6.77 | $6.93 |
| Revenue Next Year | $5.89 | $4.47 |
| P/E Ratio | $162.43 | ★ $50.41 |
| Revenue Growth | ★ 41.60 | 2.51 |
| 52 Week Low | $154.50 | $158.97 |
| 52 Week High | $262.51 | $237.54 |
| Indicator | IQV | DOV |
|---|---|---|
| Relative Strength Index (RSI) | 73.47 | 44.27 |
| Support Level | $159.91 | $200.16 |
| Resistance Level | N/A | $210.75 |
| Average True Range (ATR) | 7.47 | 3.54 |
| MACD | 0.69 | 0.03 |
| Stochastic Oscillator | 92.06 | 25.63 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.